Xenon Pharmaceuticals Inc

XENE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
XENE Income Statement
XENE Balance Sheet
XENE Cash Flow
Congress Trading

Recent trades of XENE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
XENE Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
XENE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
XENE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by XENE's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Pyridine derivatives and their use as sodium channel activators Aug. 06, 2024
  • Patent Title: Methods and uses for treating anhedonia Apr. 16, 2024
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents May. 10, 2022
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents Apr. 12, 2022
  • Patent Title: Benzenesulfonamide compouds and their use as therapeutic agents Nov. 16, 2021
  • Patent Title: Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener Oct. 05, 2021
  • Patent Title: Solid state crystalline forms of a selective potassium channel modulator Aug. 17, 2021
  • Patent Title: Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents Apr. 20, 2021
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents Oct. 27, 2020
  • Patent Title: Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors Aug. 25, 2020
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents Aug. 18, 2020
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents May. 26, 2020
  • Patent Title: Solid state forms of spiro-oxindole compounds Dec. 24, 2019
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents Apr. 02, 2019
  • Patent Title: Solid state forms of spiro-oxindole compounds Nov. 06, 2018
  • Patent Title: Asymmetric synthesis of funapide Oct. 16, 2018
  • Patent Title: Synthetic methods for spiro-oxindole compounds Jul. 04, 2017
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents Apr. 25, 2017
  • Patent Title: Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents Nov. 29, 2016
  • Patent Title: Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents Nov. 08, 2016
  • Patent Title: Biaryl ether sulfonamides and their use as therapeutic agents Nov. 01, 2016
  • Patent Title: Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents Nov. 01, 2016
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Oct. 04, 2016
  • Patent Title: Biaryl ether sulfonamides and their use as therapeutic agents Jun. 14, 2016
  • Patent Title: Methods for identifying analgesic agents Mar. 08, 2016
  • Patent Title: Synthetic methods for spiro-oxindole compounds Feb. 16, 2016
  • Patent Title: N-substituted benzamides and methods of use thereof Feb. 10, 2015
  • Patent Title: N-substituted benzamides and methods of use thereof Jan. 13, 2015
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Dec. 23, 2014
  • Patent Title: Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents Nov. 11, 2014
  • Patent Title: Synthetic methods for spiro-oxindole compounds Jun. 03, 2014
  • Patent Title: Methods and reagents for modulating cholesterol levels May. 06, 2014
  • Patent Title: Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors Sep. 24, 2013
  • Patent Title: Juvenile hemochromatosis gene (hfe2a) cleavage products and uses thereof Aug. 13, 2013
  • Patent Title: Organic compounds Aug. 06, 2013
  • Patent Title: Use of spiro-oxindole compounds as therapeutic agents Jun. 18, 2013
  • Patent Title: Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents May. 28, 2013
  • Patent Title: Synthetic methods for spiro-oxindole compounds May. 21, 2013
  • Patent Title: Spiro-oxindole compounds and their uses as therapeutic agents Apr. 09, 2013
  • Patent Title: Methods for treating pain by inhibition of the scn9a channel Apr. 02, 2013
  • Patent Title: Pyridyl derivatives and their use as therapeutic agents Feb. 26, 2013
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Sep. 11, 2012
  • Patent Title: Juvenile hemochromatosis gene (hfe2a) cleavage products and uses thereof Aug. 28, 2012
  • Patent Title: Pyridyl derivatives and their use as therapeutic agents Apr. 10, 2012
  • Patent Title: Pyridazine derivatives and their use as inhibitors of stearoyl-coa desaturase-1 activity in a mammal Apr. 03, 2012
  • Patent Title: Spiro-oxindole compounds and their uses as therapeutic agents Jan. 31, 2012
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Jan. 24, 2012
  • Patent Title: Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof Dec. 20, 2011
  • Patent Title: Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors Dec. 06, 2011
  • Patent Title: Polynucleotide encoding an atp binding cassette transporter 1 (abc1) polypeptide Nov. 29, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of XENE in WallStreetBets Daily Discussion

XENE News

Recent insights relating to XENE

CNBC Recommendations

Recent picks made for XENE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XENE

XENE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view XENE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top